Akebia Therapeutics reports strong Q2 2025 earnings, driven by Vafseo’s 55% sales growth. Explore plans for expanded patient access & trial updates.

Vidofludimus Calcium Substantially Reduced 24-Week Confirmed Disability Worsening in Phase 2 CALLIPER Trial in Overall Progressive Multiple Sclerosis ...

Discover how Vertex Pharmaceuticals achieved 12% Q2 2025 revenue growth with new launches like ALYFTREK, CASGEVY, & JOURNAVX.

The National Agency for Food and Drug Administration and Control (NAFDAC) has assured Nigerians that genetically modified ...

Variety’s 2025 class of New Leaders is an antidote to that type of thinking, proving that a time of contraction and ...

Company Announcement, European Regulatory News, GlobeNewswire, Pharmaceuticals | Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange L ...

The community of Cardigan celebrates the successful purchase and transformation of the Tabernacl Chapel into a vibrant ...

Moves in Charlotte must be planned in conjunction with the weather. The weather in the city has moods, and if you are moving in a rush, the last thing you need is a humid meltdown or a winter surprise ...